Getting Tumor Dendritic Cells to Engage the Dead

Cancer Cell. 2015 Dec 14;28(6):685-687. doi: 10.1016/j.ccell.2015.11.009.

Abstract

The immunogenic effects of chemotherapy rely on effective activation of dendritic cells to present antigen to tumor-specific T cells. However, the signals that govern how dendritic cells seek out dying cancer cells to initiate this process are poorly understood. A recent study by Vacchelli et al. provides important insight.

Publication types

  • Comment

MeSH terms

  • Animals
  • Anthracyclines / therapeutic use*
  • Female
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / immunology*
  • Receptors, Formyl Peptide / physiology*

Substances

  • Anthracyclines
  • Receptors, Formyl Peptide